These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10991642)

  • 1. High-dose ketamine in the management of cancer-related neuropathic pain.
    Tarumi Y; Watanabe S; Bruera E; Ishitani K
    J Pain Symptom Manage; 2000 Jun; 19(6):405-7. PubMed ID: 10991642
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parenteral administration of low dose ketamine for the treatment of neuropathic pain in cancer patients].
    Kong PE; Snijdelaar DG; Crul BJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2556-8. PubMed ID: 12532671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients.
    Kannan TR; Saxena A; Bhatnagar S; Barry A
    J Pain Symptom Manage; 2002 Jan; 23(1):60-5. PubMed ID: 11779670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
    Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
    Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical amitriptyline and ketamine for the treatment of neuropathic pain.
    Mercadante S
    Expert Rev Neurother; 2015; 15(11):1249-53. PubMed ID: 26488799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine: When Delirium and Desperation Call for a Hero.
    Moazam C; Hirst J; Mesarwi P; Atayee RS
    J Pain Palliat Care Pharmacother; 2019; 33(3-4):120-124. PubMed ID: 31689170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
    Amin P; Roeland E; Atayee R
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine for analgesia.
    Daley M; Roberts JC; Washington S
    Br J Hosp Med (Lond); 2012 Jun; 73(6):358. PubMed ID: 22875332
    [No Abstract]   [Full Text] [Related]  

  • 9. Analgesic effects of topical ketamine.
    Kopsky DJ; Keppel Hesselink JM; Bhaskar A; Hariton G; Romanenko V; Casale R
    Minerva Anestesiol; 2015 Apr; 81(4):440-9. PubMed ID: 24847738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intractable neuropathic pain due to ulnar nerve entrapment treated with cannabis and ketamine 10%.
    Hesselink JM; Kopsky DJ
    J Clin Anesth; 2012 Feb; 24(1):78-9. PubMed ID: 22227162
    [No Abstract]   [Full Text] [Related]  

  • 11. Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report.
    Fisher K; Hagen NA
    J Pain Symptom Manage; 1999 Jul; 18(1):61-6. PubMed ID: 10439575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic administration of ketamine for analgesia.
    Ben-Ari A; Lewis MC; Davidson E
    J Pain Palliat Care Pharmacother; 2007; 21(1):7-14. PubMed ID: 17430824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain.
    Mercadante S; Lodi F; Sapio M; Calligara M; Serretta R
    J Pain Symptom Manage; 1995 Oct; 10(7):564-8. PubMed ID: 8537699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic effect of subanesthetic intravenous ketamine in refractory neuropathic pain: a case report.
    Elsewaisy O; Slon B; Monagle J
    Pain Med; 2010 Jun; 11(6):946-50. PubMed ID: 20624244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Dynamics and Temporal Summation of Pain Predicts Neuropathic Pain Relief from Ketamine Infusion.
    Bosma RL; Cheng JC; Rogachov A; Kim JA; Hemington KS; Osborne NR; Venkat Raghavan L; Bhatia A; Davis KD
    Anesthesiology; 2018 Nov; 129(5):1015-1024. PubMed ID: 30199420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine for cancer pain: what is the evidence?
    Jonkman K; van de Donk T; Dahan A
    Curr Opin Support Palliat Care; 2017 Jun; 11(2):88-92. PubMed ID: 28306568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine for neuropathic pain: a tiger that won't bite?
    Dahan A; van Velzen M; Niesters M
    Br J Anaesth; 2020 Sep; 125(3):e275-e276. PubMed ID: 32536446
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketamine for pain: an update of uses in palliative care.
    Prommer EE
    J Palliat Med; 2012 Apr; 15(4):474-83. PubMed ID: 22500483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain.
    Kvarnström A; Karlsten R; Quiding H; Emanuelsson BM; Gordh T
    Acta Anaesthesiol Scand; 2003 Aug; 47(7):868-77. PubMed ID: 12859309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How effective is ketamine in the management of chronic neuropathic pain?
    Shteamer JW; Callaway MA; Patel P; Singh V
    Pain Manag; 2019 Nov; 9(6):517-519. PubMed ID: 31613180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.